Australia markets closed

RxSight, Inc. (RXST)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
56.17+0.40 (+0.72%)
At close: 04:00PM EDT
57.16 +0.99 (+1.76%)
Pre-market: 07:30AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
101,100
89,077
49,005
22,593
14,678
-
Cost of revenue
37,016
35,312
27,677
18,076
12,973
-
Gross profit
64,084
53,765
21,328
4,517
1,705
-
Operating expenses
Research development
29,874
29,051
25,981
24,499
21,934
-
Selling general and administrative
81,868
74,799
58,665
32,805
15,176
-
Total operating expenses
111,742
103,850
84,646
57,304
37,110
-
Operating income or loss
-47,658
-50,085
-63,318
-52,787
-35,405
-
Interest expense
1,807
3,308
4,946
3,682
510
-
Total other income/expenses net
-
-1,769
-
7,735
63,004
170,554
Income before tax
-44,467
-48,588
-66,747
-48,680
27,632
-
Income tax expense
29
20
9
8
57
-
Income from continuing operations
-44,496
-48,608
-66,756
-48,688
27,575
-
Net income
-44,496
-48,608
-66,756
-48,688
27,575
-
Net income available to common shareholders
-44,496
-48,608
-66,756
-48,688
3,366
-
Basic EPS
-1.71
-
-2.41
-3.57
0.18
1.39
Diluted EPS
-1.71
-
-2.41
-3.57
0.18
1.39
Basic average shares
32,459
-
27,662
13,625
19,073
18,784
Diluted average shares
32,459
-
27,662
13,625
19,073
18,784